English | Español

Celgene Corporation
Karen Kidd | Oct 23, 2018

Think tank founder recommends standard patents over intellectual property rights to cut drug prices
Carrice Quinnie | Jun 2, 2017

Celgene sees positive results in trial of oral ozanimod for relapsing multiple sclerosis
LocalLabs News Service | Apr 10, 2017

Oral medication reduced psoriasis symptoms, study says
Gene Johnson | Mar 10, 2017

FDA accepts Celgene Corp.'s application for leukemia treatment drug
Amanda Rupp | Aug 19, 2016

Torres, Celgene partner for psoriasis campaign
Amanda Rupp | Jun 1, 2016

World MS Day research to increase independence of MS patients
Amanda Rupp | May 16, 2016

Acute myeloid leukemia persists as major health problem
Amanda Rupp | Apr 14, 2016

WHO calls for better accessibility to psoriasis treatments

Trending
Patient Daily | Aug 18, 2025

Medfluence Advisors’ Greg Caesar to open ASCENT 2025 with keynote on digital practice growth
+ Pharmaceuticals
Patient Daily | Aug 18, 2025

Patients Come First spokesperson on 340B rebate model: ‘This rebate model provides the oversight that 340B has needed for decades’
+ Pharmaceuticals
Patient Daily | Aug 21, 2025

PhRMA director of public affairs on 340B rebate model: "Positive first step toward addressing hospital abuse of the 340B program
Patient Daily | Aug 21, 2025

SoCal Breathe Free doctor on balloon sinuplasty: ‘The procedure itself is pretty quick and effectiveness is pretty high’